Peters A L, Vervaart M A T, van Bruggen R, de Korte D, Nieuwland R, Kulik W, Vlaar A P J
Laboratory of Experimental Intensive Care and Anesthesia, Academic Medical Center, Amsterdam, The Netherlands.
Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands.
Vox Sang. 2017 Jan;112(1):25-32. doi: 10.1111/vox.12453. Epub 2016 Oct 19.
The accumulation of non-polar lipids arachidonic acid, 5-hydroxyeicosatetraenoic acid (HETE), 12-HETE and 15-HETE during storage of transfusion products may play a role in the onset of transfusion-related acute lung injury (TRALI), a syndrome of respiratory distress after transfusion.
We investigated non-polar lipid accumulation in red blood cells (RBCs) stored for 42 days, plasma stored for 7 days at either 4 or 20°C and platelet (PLT) transfusion products stored for 7 days. Furthermore, we investigated whether transfusion of RBCs with increased levels of non-polar lipids induces TRALI in a 'two-hit' human volunteer model. All products were produced following Dutch Blood Bank protocols and are according to European standards. Non-polar lipids were measured with high-performance liquid chromotography followed by mass spectrometry.
All non-polar lipids increased in RBCs after 21 days of storage compared to baseline. The non-polar lipid concentration in plasma increased significantly, and the increase was even more pronounced in products stored at 20°C. In platelets, baseline levels of 5-HETE and 15-HETE were higher than in RBCs or plasma. However, the non-polar lipids did not change significantly during storage of PLT products. Infusion of RBCs with increased levels of non-polar lipids did not induce TRALI in LPS-primed human volunteers.
We conclude that non-polar lipids accumulate in RBC and plasma transfusion products and that accumulation is temperature dependent. Accumulation of non-polar lipids does not appear to explain the onset of TRALI (Dutch Trial Register - NTR4455).
在输血制品储存过程中,非极性脂质花生四烯酸、5-羟基二十碳四烯酸(HETE)、12-HETE和15-HETE的蓄积可能在输血相关急性肺损伤(TRALI)的发病中起作用,TRALI是一种输血后呼吸窘迫综合征。
我们研究了储存42天的红细胞(RBC)、在4℃或20℃储存7天的血浆以及储存7天的血小板(PLT)输血制品中的非极性脂质蓄积情况。此外,我们在“双打击”人体志愿者模型中研究了非极性脂质水平升高的RBC输血是否会诱发TRALI。所有制品均按照荷兰血库方案生产,且符合欧洲标准。采用高效液相色谱-质谱联用技术测定非极性脂质。
与基线相比,储存21天后RBC中所有非极性脂质均增加。血浆中非极性脂质浓度显著升高,在20℃储存的制品中升高更为明显。在血小板中,5-HETE和15-HETE的基线水平高于RBC或血浆。然而,在PLT制品储存期间,非极性脂质没有显著变化。向脂多糖预处理的人体志愿者输注非极性脂质水平升高的RBC并未诱发TRALI。
我们得出结论,非极性脂质在RBC和血浆输血制品中蓄积,且蓄积与温度有关。非极性脂质的蓄积似乎无法解释TRALI的发病(荷兰试验注册编号 - NTR4455)。